Switch to: Citations

Add references

You must login to add references.
  1. Declining enrolment in a clinical trial and injurious misconceptions: is there a flipside to the therapeutic misconception?Claire Snowdon, Diana Elbourne & Jo Garcia - 2007 - Clinical Ethics 2 (4):193-200.
    The term 'therapeutic misconception' (TM) was introduced in 1982 to conceptualize how some psychiatry trial participants perceived and interpreted their involvement in research. TM has since been identified in many settings and is a major component in research ethics discussions. A qualitative study included a subgroup of interviews with five parents (two couples, one mother) who declined to enrol their baby in a neonatal trial. Analysis suggested the possibility of a counterpart to TM which, given the original terminology, we term (...)
    Download  
     
    Export citation  
     
    Bookmark   6 citations  
  • Therapeutic Misconception in Clinical Research: Frequency and Risk Factors.Paul S. Appelbaum, Charles W. Lidz & Thomas Grisso - 2004 - IRB: Ethics & Human Research 26 (2):1.
    Download  
     
    Export citation  
     
    Bookmark   60 citations  
  • Time to Stop Worrying about the Therapeutic Misconception.David S. Wendler - 2012 - Journal of Clinical Ethics 23 (3):272-287.
    Work on the therapeutic misconception suggests that investigators should ensure that potential research subjects understand the fundamental differences between clinical research and clinical care. Yet, what potential research subjects should understand depends on their circumstances and the study in question. This analysis implies that researchers and review committees should stop attempting to define, measure, and dispel the therapeutic misconception, and instead should focus on what potential subjects should understand to participate in individual studies.
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Research, engagement and public bioethics: promoting socially robust science.M. D. Pickersgill - 2011 - Journal of Medical Ethics 37 (11):698-701.
    Citizens today are increasingly expected to be knowledgeable about and prepared to engage with biomedical knowledge. In this article, I wish to reframe this ‘public understanding of science’ project, and place fresh emphasis on public understandings of research: an engagement with the everyday laboratory practices of biomedicine and its associated ethics, rather than with specific scientific facts. This is not based on an assumption that non-scientists are ‘ignorant’ and are thus unable to ‘appropriately’ use or debate science; rather, it is (...)
    Download  
     
    Export citation  
     
    Bookmark   8 citations  
  • Phase I cancer trials: A collusion of misunderstanding.Matthew Miller - 2000 - Hastings Center Report 30 (4):34-43.
    Physician‐investigators face the daunting task of enrolling desperate patients into Phase I cancer trials that are not meant to be therapeutic. Patients doggedly regard the trials as therapeutic, and researchers tend to collaborate in their confusion by glossing the trials’ true purposes and noting the occasional benefit that subjects accidentally receive. The disparity between hope and fact must be redressed by degrees, from many angles at once.
    Download  
     
    Export citation  
     
    Bookmark   30 citations  
  • The Research‐Treatment Distinction: A Problematic Approach for Determining Which Activities Should Have Ethical Oversight.Nancy E. Kass, Ruth R. Faden, Steven N. Goodman, Peter Pronovost, Sean Tunis & Tom L. Beauchamp - 2013 - Hastings Center Report 43 (s1):4-15.
    Calls are increasing for American health care to be organized as a learning health care system, defined by the Institute of Medicine as a health care system “in which knowledge generation is so embedded into the core of the practice of medicine that it is a natural outgrowth and product of the healthcare delivery process and leads to continual improvement in care.” We applaud this conception, and in this paper, we put forward a new ethics framework for it. No such (...)
    Download  
     
    Export citation  
     
    Bookmark   46 citations  
  • Research participants' "irrational" expectations: common or commonly mismeasured?S. Y. Kim, R. Vries, R. Wilson, S. Parnami, S. Frank, K. Kieburtz & R. G. Holloway - 2013 - IRB: Ethics & Human Research 35 (1):1-9.
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • An Approach to Evaluating Therapeutic Misconception.Scott Y. H. Kim, Lauren Schrock, Renee M. Wilson, Samuel A. Frank, Robert G. Holloway, Karl Kieburtz & Raymond G. De Vries - 2009 - IRB: Ethics & Human Research 31 (5):7.
    Subjects enrolled in studies testing high risk interventions for incurable or progressive brain diseases may be vulnerable to deficiencies in informed consent, such as the therapeutic misconception. However, the definition and measurement of the therapeutic misconception is a subject of continuing debate. Our qualitative pilot study of persons enrolled in a phase I trial of gene transfer for Parkinson disease suggests potential avenues for both measuring and preventing the therapeutic misconception. Building on earlier literature on the topic, we developed and (...)
    Download  
     
    Export citation  
     
    Bookmark   15 citations